Standardization of coding definitions for sickle cell disease complications: A systematic literature review

被引:0
|
作者
Ericksen, Paulette Negron [1 ]
Dabbous, Firas [2 ]
Ghosh, Rajrupa [2 ]
Shah, Surbhi [2 ]
Sun, Xunming [1 ]
Meier, Emily Riehm [1 ]
Colavecchia, Carmine [1 ]
机构
[1] Pfizer Inc, New York, NY 10001 USA
[2] Evidera, Data Analyt Real World Evidence, Bethesda, MD USA
关键词
comorbidities; complications; diagnosis codes; real-world evidence; sickle cell disease; systematic literature review; ACUTE CHEST SYNDROME; RISK-FACTORS; CLINICAL-OUTCOMES; UNITED-STATES; MORTALITY; ASSOCIATION; US; PREVALENCE; MANAGEMENT; CHILDREN;
D O I
10.1002/pds.5769
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
PurposeSickle cell disease (SCD) affects all organ systems and is characterized by numerous acute and chronic complications and comorbidities. Standardized codes are needed for complications/comorbidities used in real-world evidence (RWE) studies that rely on administrative and medical coding. This systematic literature review was conducted to produce a comprehensive list of complications/comorbidities associated with SCD, along with their diagnosis codes used in RWE studies.MethodsA search in MEDLINE and Embase identified studies published from 2016 to 2023. Studies were included if they were conducted in US SCD populations and reported complications/comorbidities and respective International Classification of Diseases, Clinical Modification (ICD-CM) codes. All identified complications/comorbidities and codes were reviewed by a certified medical coding expert and hematologist.ResultsOf 1851 identified studies, 39 studies were included. The most reported complications/comorbidities were stroke, acute chest syndrome, pulmonary embolism, venous thromboembolism, and vaso-occlusive crisis. Most of the studies used ICD-9-CM codes (n = 21), while some studies used ICD-10-CM codes (n = 3) or both (n = 15), depending on the study period. Most codes reported in literature were heterogeneous across complications/comorbidities. The medical coding expert and hematologist recommended modifications for several conditions.ConclusionWhile many studies we identified did not report their codes and were excluded from this review, the studies with codes exhibited diverse coding definitions. By providing a standardized set of diagnosis codes that were reported by studies and reviewed by a coding expert and hematologist, our review can serve as a foundation for accurately identifying complications/comorbidities in future research, and may reduce heterogeneity, enhance transparency, and improve reproducibility. Future efforts focused on validating these code lists are needed.
引用
收藏
页数:28
相关论文
共 50 条
  • [1] Prevalence, Risk Factors, and Complications of Sickle Cell Disease in Saudi Arabia: A Systematic Review
    Hamed, Nazim F.
    Alatawi, Yousef Dakheel Allah
    AlKabbani, Danya Mohammed Zuhair
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [2] Understanding the Complications of Sickle Cell Disease
    Tanabe, Paula
    Spratling, Regena
    Smith, Dana
    Grissom, Peyton
    Hulihan, Mary
    AMERICAN JOURNAL OF NURSING, 2019, 119 (06) : 26 - 35
  • [3] A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease
    Zaidi, Ahmar U.
    Glaros, Alexander K.
    Lee, Soyon
    Wang, Taiji
    Bhojwani, Rhea
    Morris, Eric
    Donohue, Breanne
    Paulose, Jincy
    Iorga, Serban R.
    Nellesen, Dave
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [4] Pulmonary complications of sickle cell disease: a narrative clinical review
    Pervaiz, Amina
    El-Baba, Firas
    Dhillon, Kunwardeep
    Daoud, Asil
    Soubani, Ayman O.
    ADVANCES IN RESPIRATORY MEDICINE, 2021, 89 (02) : 173 - 187
  • [5] Acute pulmonary complications of sickle cell disease
    Knight-Madden, Jennifer
    Greenough, Anne
    PAEDIATRIC RESPIRATORY REVIEWS, 2014, 15 (01) : 13 - 16
  • [6] Sickle Cell Disease and Its Respiratory Complications
    Khan, Mashal I.
    Patel, Naomi
    Meda, Roja T.
    Nuguru, Surya P.
    Rachakonda, Sriker
    Sripathi, Shravani
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [7] Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature
    Brandow, Amanda M.
    Farley, Rebecca A.
    Panepinto, Julie A.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (09) : 1501 - 1511
  • [8] Sickle cell disease: a review for the internist
    Pinto, Valeria Maria
    Balocco, Manuela
    Quintino, Sabrina
    Forni, Gian Luca
    INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (07) : 1051 - 1064
  • [9] Intracranial Aneurysm in Patients with Sickle Cell Disease: A Systematic Review
    Yao, Zhong
    Li, Jin
    He, Min
    You, Chao
    WORLD NEUROSURGERY, 2017, 105 : 302 - 313
  • [10] Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature
    Hoogenboom, Wouter S.
    Alamuri, Tharun T.
    McMahon, Daniel M.
    Balanchivadze, Nino
    Dabak, Vrushali
    Mitchell, William B.
    Morrone, Kerry B.
    Manwani, Deepa
    Duong, Tim Q.
    BLOOD REVIEWS, 2022, 53